Elanco Animal Health Incorporated (ELAN) vs Lantheus Holdings, Inc. (LNTH)
Elanco Animal Health Incorporated and Lantheus Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Elanco Animal Health Incorporated is the larger, with a market value of $11.2B against $6.5B — 1.7× the size. Elanco Animal Health Incorporated has negative trailing earnings, so its P/E is not meaningful; Lantheus Holdings, Inc. trades at 23.7×. Elanco Animal Health Incorporated grew revenue faster over the last twelve months: 12.0% against 2.35%. Lantheus Holdings, Inc. has the higher net margin (17.7% vs −3.96%) and the higher return on invested capital (14.7% vs 0.51%). Across the 20 metrics below, Lantheus Holdings, Inc. leads on 16 and Elanco Animal Health Incorporated on 4.
Valuation
Profitability
| Metric | ELAN | LNTH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 55.36% | 60.14% | 53.94% |
| Operating margin | 1.61% | 19.43% | 0.00% |
| Net margin | (3.96%) | 17.69% | 0.00% |
| Free cash flow margin | 7.55% | 25.24% | 0.00% |
| Return on equity | (2.98%) | 22.21% | (0.40%) |
| Return on assets | (1.46%) | 12.15% | (3.32%) |
| Return on invested capital | 0.51% | 14.65% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack